Volume 9, Number 11, November 2003

Levofloxacin Treatment Failure in Haemophilus influenzae Pneumonia

Teresa Bastida,* María Pérez-Vázquez,† José Campos,† María Cristina Cortés-Lletget,‡ Federico Román,† Fe Tubau,§ Adela G. de la Campa,† and Carles Alonso-Tarrés‡
*Hospital de l´Esperit Sant, Santa Coloma de Gramenet, Barcelona, Spain; †Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain; ‡Hospital de l’Hospitalet, Consorci Sanitari Integral, L’Hospitalet de Llobregat, Barcelona, Spain; and §Hospital “Prínceps d’Espanya” Ciutat Sanitària i Universitària de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain

Figure. Pulsed-field gel electrophoresis patterns of the three clinical isolates of levofloxacin-resistant Haemophilus influenzae from the case report (lanes 1 to 3) and four control cases of levofloxacin-susceptible H. influenzae biotype II strains isolated from the same geographic area (lanes 4 to 7). Lane 1: strain 32602 (blood); lane 2: strain 35102 (blood); lane 3: strain 35202 (bronchial aspirate); lane 4: pleural fluid isolate; lane 5: blood isolate; lane 6: pleural fluid isolate. M, molecular markers.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed October 2, 2003

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention